Skip to main content
Smart Investors Daily
CR

NASDAQ · CRON

Cronos Group Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$3.38

Up+$0.15 (+4.29%)

Updated Nov 4, 2026, 8:57 PM

SID Score

6.4/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.09B
P/E ratio
59.51
Dividend yield
0.00%
52-week range
$2.38 – $3.61
Volume
1.13M
Avg. volume
1.99M

Price performance · CRON

CRON price history

1M range · 0 trading sessions · Daily adjusted prices

CRON does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest CRON news

The latest Smart Investors Daily articles mentioning CRON.

CRON research

Overview

Company profile and research snapshot.

Company profile

Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$3.43
Implied upside
—
Analysts
7
CRON recent ratings
DateFirmRatingTarget
Aug 10, 2026CANACCORD GENUITYBuy—
Aug 7, 2026TD COWENBuy—
Aug 6, 2026ROTH CAPITAL PARTNERSBuy—
May 12, 2026CANACCORD GENUITYBuy—
May 11, 2026CANACCORD GENUITYBuy—
Open full forecast

News briefing

Generated Nov 4, 2026, 9:16 PM

Why Is CRON Up Today?

Cronos Group Inc. gained 3.85% today, climbing $0.13 as the Canadian cannabis company continues to attract investor attention amid sector consolidation discussions. The stock's movement appears driven by positive positioning in multiple analyst watch lists rather than company-specific catalysts, reflecting renewed interest in select cannabis plays heading into late 2026.

    Bottom line: Cronos Group's 3.85% gain appears to reflect renewed sector interest rather than company-specific news, as the stock was mentioned in analyst watchlists for Canadian penny stocks. While the cannabis sector offers long-term upside potential, investors should monitor upcoming earnings reports and regulatory developments before adding positions, as CRON remains a speculative play with execution risks.

    Yahoo · Nov 4, 2026

    Top 3 Canadian Penny Stocks To Watch In November 2026

    The recent rally in Suncor’s profit and cash flow has pushed Canadian energy back into the spotlight, reminding investors how quickly capital can return to commodity producers when conditions line up. That kind of story makes financially solid, low-priced Canadian stocks especially interesting. You get exposure to potential upside with a focus on balance sheet strength. This article highlights three financially healthier penny stocks filtered for that profile. The three stocks highlighted...

    Yahoo · Nov 2, 2026

    Cronos Group And 2 Other Canadian Penny Stocks To Own

    Oil prices still reflect a war premium, with supply risks and depleted buffers keeping energy costs elevated. That kind of backdrop often punishes weaker balance sheets and rewards sturdier ones. For Canadian penny stocks with stronger finances and low dilution, that can create a rare entry window before attention broadens. This article highlights three such smaller companies that combine healthier finances, insider commitment and recent share price momentum. The three penny stocks covered...

    Yahoo · Oct 31, 2026

    Thor Explorations And 2 Canadian Penny Stocks To Watch

    AI enthusiasm in big tech has cooled as investors question heavy spending on data centers and chips. That pullback has shifted attention to smaller Canadian companies where every dollar is watched closely and balance sheets matter. Financially disciplined penny stocks can offer exposure to early stage growth, with tighter cost control and less hype. This article highlights three financially healthier Canadian penny stocks from our screener that may be worth a closer look. The three stocks...

    AI research layers

    Interpretive context generated from the platform’s current data sources.

    No results

    AI research layers have not been published yet.